Innotech: The company and its subsidiaries have recently obtained 3 product qualifications and 1 registration change.

Inotek announced that the company and its wholly-owned subsidiary, Tangshan Inotek, have recently obtained three new product qualifications, including one each for China, Myanmar, and Vietnam, such as the chikungunya virus nucleic acid detection kit; they also received one change registration for a medical device, primarily for a change in the expected use of the product, adding nasal swab sampling and consumer self-testing. These qualifications broaden the range of products and enhance market expansion capabilities and core competitiveness, but actual product sales are affected by various factors, so the impact on performance remains uncertain.